With the trading day about halfway over, the markets were moving higher, after being stuck in the doldrums for the first half of the week. Oil pushed back above $70
Continue reading »Home »
Biogen’s Aduhelm Gets FDA Approval – A New Drug For Alzheimer’s In 18 Years, Priced At $56,000/Yr
A new treatment for Alzheimer’s in 18 years has made it to the finish line, thanks to the FDA approval of Aduhelm. Aduhelm, developed by Biogen Inc.(BIIB)/Eisai Co., Ltd., has
Continue reading »